Additionally, PTPN6, through the SHP-1/JAK2/STAT3 signaling pathway, plays an important role in the treatment of osteosarcoma, hepatocellular carcinoma, and leukemia [7,8,9]. Here, PTPN6 is linked to hepatocellular carcinoma.